An up-to-30 year prospective study with 37747 participants in Denmark observed a 10-fold higher IgE level in non-Hodgkin lymphoma, oral or pharynx cancer, lung cancer, and esophagus cancer. This evidence concerns the gene IGHE and lung carcinoma.